Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Yoshitsu Co., Ltd Reports First Six Months of Fiscal Year 2024 Financial Results 2023-12-22 19:00
Oncoshot Teams Up with Zhejiang Ablaze Medicine to Drive Data-Powered Drug Development in China 2023-12-22 13:26
A Pioneer in Data Analytics Excellence: SIFT Analytics Group Drives Digital Transformations for Over 1,000 Businesses Across Southeast Asia 2023-12-22 11:27
Davos Communications Awards - BGI Genomics Inclusive Instagram Strategy Wins Gold Recognition 2023-12-22 08:19
Juniper Therapeutics Acquires Exclusive Rights for SAR Registration for Anti-Viral COVID-19 Drug from Ping An-Shionogi Hong Kong for Singapore 2023-12-22 07:00
Jung Kwan Jang to Boost the Popularity of Red Ginseng by Employing various forms, from Film to Jelly 2023-12-22 07:00
TransThera Announces the Global Multicenter Phase 3 Clinical Trial Completed First Patient Dosing in the US Evaluating Tinengotinib in FGFRi Relapsed/Refractory Patients with Cholangiocarcinoma 2023-12-21 21:45
International Clinical Trial Results Released! Responding to the Virus Resurgence, Lianhua Qingwen Capsules Provide New Evidence 2023-12-21 18:06
CStone sells to Servier its exclusive rights to TIBSOVO® in Greater China and Singapore 2023-12-21 17:10
Everest Medicines' Partner Calliditas Therapeutics Announces Nefecon® the Only FDA-approved Treatment for IgA Nephropathy to Significantly Slow Kidney Function Decline 2023-12-21 10:30
EVERISE ANNOUNCES SUCCESSFUL CLOSURE OF INVESTMENT BY WARBURG PINCUS, JOINING BROOKFIELD FOR THE NEXT PHASE OF GROWTH 2023-12-21 10:16
ENA Building Momentum Globally in Support of Emergency Nurses 2023-12-21 09:00
BioCity announces the first patient dosed with its anti-TIM-3 mAb BC3402 in Combination with IMFINZI for the Treatment of Advanced Hepatocellular Carcinoma in a Phase Ib/II Trial 2023-12-21 08:26
YS Biopharma Responds to Unauthorized Press Release Regarding Extraordinary General Meeting 2023-12-21 05:30
/DISREGARD RELEASE: YS Biopharma/ 2023-12-21 05:15
CellOrigin announced treatment of the first patient with CAR-M in China and reported the second generation of CAR-M for solid tumors 2023-12-21 01:00
EpiVax Licenses ISPRI Toolkit to Eisai for Preclinical in silico Immunogenicity Screening 2023-12-20 23:45
Genevoyager Unveils Gene Therapy CDMO Facility in Milestone Move 2023-12-20 23:10
Dx&Vx co-develops a bio-healthcare big data platform with LG CNS 2023-12-20 22:00
HanAll Biopharma, Daewoong Pharmaceutical and NurrOn Pharmaceuticals to Showcase Ongoing Parkinson's Disease Program at the 7th Annual Sachs Associates Neuroscience Innovation Forum 2023-12-20 20:00
1 51 52 53 54 55 1502